CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 2 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-19 | Bright Rex Director | Grant or award · Stock Options | +20,500 | 20,500 | ||
| 2021-07-19 | Basta Steven L Director | Grant or award · Stock Options | +20,500 | 20,500 | ||
| 2021-07-19 | BARBARI SHARON Director | Grant or award · Stock Options | +20,500 | 20,500 | ||
| 2021-06-30 | Zeronda Tyler Interim CFO | Shares withheld for taxes | −700 | $3.51 | $2K | 22,695 |
| 2021-06-30 | Wiley Matthew T. Chief Commercial Officer | Shares withheld for taxes | −5,151 | $3.51 | $18K | 109,246 |
| 2021-06-30 | Stuart Iain Chief Scientific Officer | Shares withheld for taxes | −3,083 | $3.51 | $11K | 95,750 |
| 2021-06-30 | Harsch Mutya Chief Legal Officer and GC | Shares withheld for taxes | −3,551 | $3.51 | $12K | 105,322 |
| 2021-06-30 | Domzalski David President and CEO | Shares withheld for taxes | −18,859 | $3.51 | $66K | 455,599 |
| 2021-05-28 | Saik Andrew Chief Financial Officer | Grant or award | +3,017 | $3.36 | $10K | 116,468 |
| 2021-05-28 | Domzalski David President and CEO | Grant or award | +941 | $3.36 | $3K | 474,458 |
| 2021-05-26 | LEPORE PATRICK G Director | Purchase | +12,500 | $3.60 | $45K | 37,500 |
| 2021-05-06 | PERCEPTIVE ADVISORS LLC 10% owner | Sale | −1,000,000 | $3.67 | $3.7M | 5,773,954 |
| 2021-03-31 | Wiley Matthew T. Chief Commercial Officer | Shares withheld for taxes | −2,573 | $6.84 | $18K | 114,397 |
| 2021-03-31 | Stuart Iain Chief Scientific Officer | Shares withheld for taxes | −1,945 | $6.84 | $13K | 98,833 |
| 2021-03-31 | Saik Andrew Chief Financial Officer | Shares withheld for taxes | −762 | $6.84 | $5K | 113,451 |
| 2021-03-31 | Harsch Mutya Chief Legal Officer and GC | Shares withheld for taxes | −1,765 | $6.84 | $12K | 108,873 |
| 2021-03-31 | Domzalski David President and CEO | Shares withheld for taxes | −6,316 | $6.84 | $43K | 473,517 |
| 2021-03-15 | LEPORE PATRICK G Director | Purchase | +12,500 | $7.41 | $93K | 25,000 |
| 2021-02-22 | Wiley Matthew T. Chief Commercial Officer | Grant or award | +27,675 | 116,970 | ||
| 2021-02-22 | Wiley Matthew T. Chief Commercial Officer | Grant or award · Stock Options | +64,575 | 64,575 |
Page 10 of 22 · 425 trades